Announcements Trials
Browse Landscape

Status

Terminated 1

Sponsor Class

INDUSTRY 1

Study Type

Observational 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 2046Neoplasms 1458Carcinoma, Non-Small-Cell Lung 1362Prostatic Neoplasms 1106Multiple Myeloma 872Leukemia, Myeloid, Acute 770Colorectal Neoplasms 712Neoplasm Metastasis 704Lung Neoplasms 697Melanoma 687Lymphoma 666Leukemia 595Lymphoma, Non-Hodgkin 593Leukemia, Lymphocytic, Chronic, B-Cell 535Ovarian Neoplasms 532Pancreatic Neoplasms 500Precursor Cell Lymphoblastic Leukemia-Lymphoma 485Recurrence 474Myelodysplastic Syndromes 424Lymphoma, Follicular 418Carcinoma, Renal Cell 411Head and Neck Neoplasms 408Glioblastoma 380Lymphoma, Large B-Cell, Diffuse 379Brain Neoplasms 375Hodgkin Disease 354Carcinoma, Hepatocellular 333Squamous Cell Carcinoma of Head and Neck 326Lymphoma, Mantle-Cell 306Sarcoma 286

Interventions

exemestane 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Invasive Early Breast Cancer × Clear all
NCT01121549 2014-01-22

A Non-Interventional Study With AromasinĀ® As Adjuvant Treatment Of Invasive Early Breast Cancer

Pfizer

Terminated
378 enrolled 16 charts
Breast

Invasive Early Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚔